Arcadia Biosciences, Inc.

NasdaqCM:RKDA Stock Report

Market Cap: US$3.9m

Arcadia Biosciences Valuation

Is RKDA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RKDA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate RKDA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate RKDA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RKDA?

Key metric: As RKDA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for RKDA. This is calculated by dividing RKDA's market cap by their current revenue.
What is RKDA's PS Ratio?
PS Ratio0.7x
SalesUS$5.18m
Market CapUS$3.87m

Price to Sales Ratio vs Peers

How does RKDA's PS Ratio compare to its peers?

The above table shows the PS ratio for RKDA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.7x
SANW S&W Seed
0.2x-21.0%US$7.0m
SVIN Scheid Vineyards
0.09xn/aUS$6.3m
CUBX.F CubicFarm Systems
10.3xn/aUS$3.9m
EDBL Edible Garden
0.08x26.2%US$1.2m
RKDA Arcadia Biosciences
0.7x20.3%US$3.9m

Price-To-Sales vs Peers: RKDA is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (2.7x).

Price to Sales Ratio vs Industry

How does RKDA's PS Ratio compare vs other companies in the US Food Industry?

26 CompaniesPrice / SalesEstimated GrowthMarket Cap
BG Bunge Global
0.2x3.5%US$12.50b
DOLE Dole
0.2x0.7%US$1.40b
FARM Farmer Bros
0.1x4.6%US$41.47m
BHIL Benson Hill
0.05xn/aUS$29.02m
RKDA 0.7xIndustry Avg. 0.9xNo. of Companies26PS012345+
26 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: RKDA is good value based on its Price-To-Sales Ratio (0.7x) compared to the US Food industry average (0.9x).

Price to Sales Ratio vs Fair Ratio

What is RKDA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RKDA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.7x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: RKDA is expensive based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst RKDA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$2.66
US$9.00
+239.0%
33.3%US$12.00US$6.00n/a2
Nov ’25US$3.84
US$9.00
+134.6%
33.3%US$12.00US$6.00n/a2
Oct ’25US$2.85
US$9.00
+215.8%
33.3%US$12.00US$6.00n/a2
Sep ’25US$3.11
US$9.00
+189.6%
33.3%US$12.00US$6.00n/a2
Aug ’25US$2.93
US$9.00
+207.2%
33.3%US$12.00US$6.00n/a2
Jul ’25US$3.10
US$9.00
+190.3%
33.3%US$12.00US$6.00n/a2
Jun ’25US$3.06
US$9.00
+194.1%
33.3%US$12.00US$6.00n/a2
May ’25US$2.05
US$11.00
+436.6%
9.1%US$12.00US$10.00n/a2
Apr ’25US$2.05
US$11.00
+436.6%
9.1%US$12.00US$10.00n/a2
Mar ’25US$2.75
US$11.00
+300.0%
9.1%US$12.00US$10.00n/a2
Feb ’25US$2.42
US$11.00
+354.5%
9.1%US$12.00US$10.00n/a2
Jan ’25US$3.13
US$11.00
+251.4%
9.1%US$12.00US$10.00n/a2
Dec ’24US$2.88
US$11.00
+281.8%
9.1%US$12.00US$10.00n/a2
Nov ’24US$3.25
US$15.00
+361.5%
33.3%US$20.00US$10.00US$3.842
Oct ’24US$3.35
US$15.00
+347.8%
33.3%US$20.00US$10.00US$2.852
Sep ’24US$3.96
US$15.00
+278.8%
33.3%US$20.00US$10.00US$3.112
Aug ’24US$4.32
US$17.50
+305.1%
14.3%US$20.00US$15.00US$2.932
Jul ’24US$3.88
US$17.50
+351.0%
14.3%US$20.00US$15.00US$3.102
Jun ’24US$4.70
US$19.00
+304.3%
5.3%US$20.00US$18.00US$3.062
May ’24US$6.02
US$19.00
+215.6%
5.3%US$20.00US$18.00US$2.052
Feb ’24US$10.80
US$100.00
+825.9%
20.0%US$120.00US$80.00US$2.422
Jan ’24US$10.84
US$100.00
+822.5%
20.0%US$120.00US$80.00US$3.132
Dec ’23US$13.20
US$100.00
+657.6%
20.0%US$120.00US$80.00US$2.882
Nov ’23US$14.40
US$130.00
+802.5%
7.7%US$140.00US$120.00US$3.252

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Arca Continental. de

Mex$294.5b

Produces, distributes, and sells soft drinks in Mexico, Peru, the United States, Argentina, and Ecuador.

EMBV.F

Mex$8.41

7D

2.2%

1Y

-16.0%

B&G Foods

US$503.5m

Manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products in the United States, Canada, and Puerto Rico.

BGS

US$6.27

7D

-0.3%

1Y

-33.2%

Local Bounti

US$15.6m

Local Bounti Corporation grows and packs fresh greens in the United States.

LOCL

US$1.71

7D

-26.8%

1Y

-55.6%